© 2021 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
April 04, 2017
Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.
April 03, 2017
Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.
Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.
April 02, 2017
Researchers investigated possible differences in the function of the striatum both before and after the development of obesity.
Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.
March 31, 2017
You won’t want to miss these top sessions and new features at this year’s Endocrinology Society’s annual meeting, April 1-4, in Orlando, FL.
July 20, 2016
Follow-up data from the landmark Diabetes Prevention Study examined the role of physical activity in diabetes prevention.
July 12, 2016
This slideshow highlights several studies regarding the effects of SGLT2 inhibitors, which were presented at the 2016 ADA Scientific Sessions.
July 01, 2016
Several studies presented at ADA 2016 discussed going beyond basal insulin treatments for patients with type 2 diabetes.
June 16, 2016
A secondary analysis of data from the Insulin Resistance Intervention after Stroke trial (IRIS) examined pioglitazone’s effect on diabetes prevention.